









Markets
/
Stocks
/
nasdaq-vnda
/

Vanda Pharmaceuticals Inc

VNDA

View Detailed Chart

4.190USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

247.55MMarket Cap

LossP/E TTM



Vanda Pharmaceuticals Inc

4.190

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-1.64%

5 Days

-11.60%

1 Month

-15.69%

6 Months

-2.78%

Year to Date

-12.53%

1 Year

-22.41%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

BUY

Current Rating

12.667

Target Price

202.31%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Vanda Pharmaceuticals Inc

VNDA

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(7)

Neutral(2)

Buy(0)

Indicators

Sell(1)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.150

Neutral

RSI(14)

32.213

Neutral

STOCH(KDJ)(9,3,3)

10.532

Oversold

ATR(14)

0.184

Low Volatility

CCI(14)

-251.299

Oversold

Williams %R

96.341

Oversold

TRIX(12,20)

-0.073

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

4.500

Sell

MA10

4.624

Sell

MA20

4.746

Sell

MA50

4.617

Sell

MA100

4.534

Sell

MA200

4.635

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Vanda Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in smith-magenis syndrome (SMS), Fanapt (iloperidone) for the treatment of bipolar I disorder and a long acting injectable (LAI) formulation for the treatment of schizophrenia, and PONVORY (ponesimod) for the treatment of inflammatory/autoimmune disorders, including ulcerative colitis, psoriasis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. The Company also has a range of drugs in development, including Tradipitant (VLY-686), VHX-896, VSJ-110, VPO-227, VTR-297, VQW-765, VCA-894A and Type 2S (CMT2S).

Ticker SymbolVNDA

CompanyVanda Pharmaceuticals Inc

CEODr. Mihael Hristos Polymeropoulos, M.D.

Websitehttps://www.vandapharma.com/